Toggle Health Problems and D

Hospital-acquired pneumonia treated by vitamin D if person was deficient – RCT Sept 2018

Effect of adjunctive single high-dose vitamin D3 on outcome of community-acquired pneumonia in hospitalised adults: The VIDCAPS randomised controlled trial.

Sci Rep. 2018 Sep 14;8(1):13829. doi: 10.1038/s41598-018-32162-2.
Slow S1, Epton M2, Storer M2, Thiessen R3, Lim S3, Wong J4,5, Chin P4,6, Tovaranonte P4,7, Pearson J8, Chambers ST8, Murdoch DR8; VIDCAPS Group.

  • 200,000 IU of oral vitamin D helped those who got pneunomia while in hospital and were Vit D deficient ( < 10 ng)
  • Small Randomized Controlled Trial (60 in each group), so the results are not statistially significant
  • 13X more likely to have complete resolution if initially < 10 ng and were in the group getting the 200,000 IU

CAP Death with low Vitamin D

CAP Children

Breathing category starts with the following

424 items in Breathing category

Breathing-related Overviews at VitaminDWiki:
Allergy   Lung Cancer   TB   Asthma  Influenza  Colds and flu
Pneumonia   Respiratory infections   COPD   Air Polution   Smoking   Cystic Fibrosis

 Download the PDF from VitaminDWiki

Note: (XX) XX =%

Low vitamin D status is associated with increased risk of pneumonia, greater disease severity and poorer outcome. However, no trials have examined the effect of adjunctive vitamin D therapy on outcomes in adults with community-acquired pneumonia (CAP). We conducted a randomised, double-blind, placebo-controlled trial examining the effects of adjunctive vitamin D in adults hospitalised with CAP. Participants were randomised to either a single oral dose of 200,000 IU vitamin D3 or placebo. The primary outcome was the complete resolution of chest radiograph infiltrate at 6 weeks post-study treatment. Secondary outcomes included length of hospital stay, intensive care admission and return to normal activity. Only participants who completed the study or died within the 6 week period were included in the analysis (n = 60 vitamin D, n = 57 placebo). Adjunctive vitamin D did not have any effect on the primary outcome (OR 0.78, 95% CI 0.31 to 1.86, p = 0.548).
However, there was evidence it increased the complete resolution of pneumonia in participants with baseline vitamin D levels <25 nmol/L (OR 17.0, 95% CI 1.40-549.45, P = 0.043), but this did not reach statistical significance using exact methods (OR 13.0, 95%CI 0.7-960.4, P = 0.083). There were no significant effects for any secondary outcome.

Created by admin. Last Modification: Sunday October 6, 2019 23:23:54 GMT-0000 by admin. (Version 6)

Attached files

ID Name Comment Uploaded Size Downloads
10552 Pneu.jpg admin 16 Sep, 2018 14:09 90.71 Kb 430
10551 community-acquired pneumonia.pdf PDF 2018 admin 16 Sep, 2018 14:09 1.05 Mb 419
See any problem with this page? Report it (WORKS NOV 2021)